Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment
Abstract Sensitivity of cell-free circulating tumour DNA (ctDNA) assays is often hampered by the limited quantity of intact mutant nucleotide fragments. To overcome the issue of substrate limitation in clinical applications, we developed an enrichment method utilizing pyrrole-imidazole (PI) polyamid...
Guardado en:
Autores principales: | Yoshiyasu Kitagawa, Kazuhiro Okumura, Takayoshi Watanabe, Kei Tsukamoto, Shiro Kitano, Rino Nankinzan, Takuto Suzuki, Taro Hara, Hiroaki Soda, Tadamichi Denda, Taketo Yamaguchi, Hiroki Nagase |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2053aba583244414bcf40be73b7b6ae7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Children passively allow other’s rule violations in cooperative situations
por: Ayaka Ikeda, et al.
Publicado: (2018) -
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
por: Nicolas Bery, et al.
Publicado: (2020) -
Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
por: Jieqiong Wang, et al.
Publicado: (2016) -
Oncogenic KRAS: Signaling and Drug Resistance
por: Hyeon Jin Kim, et al.
Publicado: (2021) -
Flexible interlocked porous frameworks allow quantitative photoisomerization in a crystalline solid
por: Yongtai Zheng, et al.
Publicado: (2017)